Biblio
Export 136 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is R [Clear All Filters]
“Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 899-910, 2018.
, “Quantifying the Diagnostic Pathway for Patients with Cognitive Impairment: Real-World Data from Seven European and North American Countries.”, J Alzheimers Dis, vol. 62, no. 1, pp. 457-466, 2018.
, “The Association between Montreal Cognitive Assessment Memory Scores and Hippocampal Volume in a Neurodegenerative Disease Sample.”, J Alzheimers Dis, vol. 58, no. 3, pp. 695-699, 2017.
, “Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric Inpatients.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1319-1331, 2016.
, “Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.”, J Alzheimers Dis, vol. 55, no. 2, pp. 625-644, 2017.
, “Detection of Dementia Cases in Two Swedish Health Registers: A Validation Study.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1301-1310, 2018.
, “A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes.”, J Alzheimers Dis, vol. 96, no. 2, pp. 591-607, 2023.
, “Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 1, pp. 325-35, 2016.
, “Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 69-78, 2017.
, “When Patient Engagement and Research Ethics Collide: Lessons from a Dementia Forum.”, J Alzheimers Dis, vol. 59, no. 1, pp. 1-10, 2017.
, “Health Advice in a Digital World: Quality and Content of Online Information about the Prevention of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 219-229, 2017.
, “The Online Environment: A Key Variable in the Ethical Response to Complementary and Alternative Medicine for Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 11-3, 2016.
, “Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology.”, J Alzheimers Dis, vol. 57, no. 2, pp. 317-330, 2017.
, “Pathological Correlates of Cognitive Impairment in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age.”, J Alzheimers Dis, 2018.
, “The Contribution of Vascular Pathology Toward Cognitive Impairment in Older Individuals with Intermediate Braak Stage Tau Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1005-1015, 2020.
, “Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.”, J Alzheimers Dis, vol. 75, no. 2, pp. 437-450, 2020.
, “Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1085-1090, 2018.
, “Fragmentation of the Golgi Apparatus in Neuroblastoma Cells Is Associated with Tau-Induced Ring-Shaped Microtubule Bundles.”, J Alzheimers Dis, 2018.
, “JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 4, pp. 963-7, 2016.
, “Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
, “Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus.”, J Alzheimers Dis, vol. 52, no. 1, pp. 161-9, 2016.
, “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
, “Clinical Conversion or Reversion of Mild Cognitive Impairment in Community versus Hospital Based Studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea).”, J Alzheimers Dis, vol. 53, no. 2, pp. 463-73, 2016.
, “Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?”, J Alzheimers Dis, vol. 50, no. 3, pp. 645-58, 2016.
, “Cerebral Oxidative Stress and Microvasculature Defects in TNF-α Expressing Transgenic and Porphyromonas gingivalis-Infected ApoE-/- Mice.”, J Alzheimers Dis, vol. 60, no. 2, pp. 359-369, 2017.
,